Skip to main content
Erschienen in: Neurological Sciences 12/2020

Open Access 22.07.2020 | Review Article

Endovascular treatment of ischemic large-vessel stroke due to infective endocarditis: case series and review of the literature

verfasst von: Lucio D’Anna

Erschienen in: Neurological Sciences | Ausgabe 12/2020

Abstract

Background

Mechanical thrombectomy is the standard of care, in selected patients, for acute ischemic stroke with large vessel occlusion but its use in patients with stroke secondary to infective endocarditis is controversial. We report three cases of acute ischemic stroke treated by mechanical thrombectomy and we propose an extensive review of the literature to evaluate the clinical safety and efficacy of thrombectomy in patients with stroke secondary to infective endocarditis.

Methods

A comprehensive literature search was performed following a pre-specified protocol of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Case reports, cases series, cross-sectional studies, case control studies, randomized controlled trials or nonrandomized controlled trials were considered that included endocarditis-related acute ischemic stroke patients who underwent mechanical thrombectomy.

Results

The database search yielded 431 relevant records published until January 2020. Nineteen articles fulfilled the eligibility criteria that described thirty patients. After the thrombectomy, 13.3% of the patients experienced intracranial haemorrhage. After the procedure, the median National Institutes of Health Stroke Scale score dropped from 15 (IQR 7) to 2.5 (IQR 5.75). At 90 days, mortality was 23.3% while 46.7% of the patients were functionally independent (mRS ≤ 2).

Discussion

Based on our review, the use of mechanical thrombectomy in patients with large vessel occlusion due to endocarditis-associated stroke might improve patient outcome but it should be considered on a case by case base as the safety has not been well established yet. Further research on risk stratification is needed to drive clinician during the decision-making process.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Acute ischemic stroke is the most common neurological complication of infective endocarditis, manifesting clinically in 20–40% of the patients [1, 2]. Conversely, complications may be completely silent as asymptomatic ischemia can occur in another 30–40% of patients [3]. Patients with stroke secondary to infective endocarditis have a severe prognosis leaving only less than one-third of patients alive with functional independence [4].
Treatment of patients with acute stroke secondary to infective endocarditis is suboptimal as thrombolytic therapy is contraindicated due to high risk of haemorrhagic transformation of the infarct [5]. Mechanical thrombectomy is the standard of care, in selected patients, for acute ischemic stroke with large vessel occlusion. However, its efficacy and safety in patients with stroke secondary to infective endocarditis have limited evidence in the literature. Then, there is an urgent need of improved treatment for patients with stroke secondary to infective endocarditis.
We report here a case series of patients with stroke secondary to infective endocarditis treated with mechanical thrombectomy and a review of the current available literature on this issue.

Methods

Search strategy and study selection

We performed a systematic review following PRISMA (Fig. 1) guidance [6]. Systematic search for the reports published until January 2020 was conducted in PubMed, Cochrane, SciELO, B-on, Google scholar and clinical trial registries for relevant articles. Reference lists from all included articles and abstracts were also assessed for any additional relevant studies not identified through the initial search. For those meeting the eligibility criteria, full-text articles were obtained. Pre-defined eligibility criteria were applied. For the search strategy, we combined the terms ‘stroke and endocarditis’ with ‘thrombectomy’. We did also the same search, but without the word ‘stroke’.

Eligibility criteria

Only reports published in English were considered. We included randomized or nonrandomized controlled trials, case control studies, cross-sectional studies, case series and case reports that reported the treatment of patients (> 18 years old) with acute stroke secondary to infective endocarditis with mechanical thrombectomy. Title and abstracts of all retrieved articles were assessed for inclusion.

Data collection process

We extracted the following information from the reports: age, gender, site of the infective endocarditis, presence or not of atrial fibrillation, treatment with oral anticoagulant or not, blood culture pathogen, baseline National Institutes of Health Stroke Scale (NIHSS) scores, treatment with intravenous thrombolysis and site of the large vessel occlusion. We also extracted as neuroradiological outcome the presence of intracranial haemorrhage after treatment and the thrombolysis in cerebral infarction (TICI) [7] scale score defined as grade 0, no perfusion; grade 1, penetration with minimal perfusion; grade 2A, only partial filling of the entire vascular territory visualised; grade 2B, complete filling of all the expected vascular territories visualised but the filling is slower than normal; and grade 3, complete perfusion. We documented the endovascular revascularization technique used, the NIHSS score after treatment and the modified Rankin Scale (mRS) at follow-up. Whenever any data is not provided, it was documented as not reported (NR).

Risk of bias in individual studies

The quality of the articles was examined according to the Quality Assessment Tool for Case Series Studies of National Heart, Lung, and Blood Institute and to the Case Reporting Guidelines of Care (2013).

Data synthesis

We summarised the data obtained in Table 1. In Table 2, we provided the % of patients with mRS score 0–1 and 0–2 at 90 days. We have also calculated the median (IQR) of the NIHSS at 24 h after the mechanical thrombectomy and the median (IQR) change in NIHSS score from baseline to 24 h after the procedure.
Table 1
Characteristics of patients with stroke and infective endocarditis treated with mechanical thrombectomy
Authors
Age/sex
Site of the IE
AF
Treatment of OAC
Blood culture pathogen
Onset NIHSS score
Treatment with IV thrombolysis
LVO site
TICI
Endovascular revascularization technique
ICH
NIHSS outcome
mRS at follow-up
D’Anna
67/M
Mitral valve
No
No
Gemella morbillorum
17
No
M1
3
Aspiration
No
0–24 h after
0 at 90 days
D’Anna
30/F
Aortic valve
No
No
Neisseria gonorrhoeae
22
No
Distal ICA
2a
Aspiration and stent retriever
Yes
22–24 h after
3 at 90 days
D’Anna
65/F
Mitral valve
No
No
Staphylococcus aureus
18
NR
M2
0
Aspiration
No
21–24 h after
4 at 90 days
Sloane et al.
59/F
Mitral valve
No
No
Negative
21
No
M1
2B
Stent retriever
No
6 after the procedure
1 at 180 days
Distefano et al.
75/M
Aortic valve
No
No
Enterococcus faecalis
16
Yes
M1
NR (recanalised)
Aspiration
Yes
NR
6 few days later
Sgreccia et al.
31/M
Aortic valve
No
No
Candida parapsilosis
18
Yes
ICA bifurcation
3
Stent retriever
No
0–48 h later
0 at 90 days
Ambrosioni et al.
79/M
Prosthetic (mechanical)
NR
Yes
Staphylococcus aureus
9
NR
M1 and ICA
0
Stent retriever
No
35–24 h after
6 at 7 days
Ambrosioni et al.
69/ F
Prosthetic (mechanical)
NR
Yes
Streptococcus oralis
10
NR
Basilar
3
Stent retriever
No
2–24 h after
0 at 7 and 90 days
Ambrosioni et al.
56/F
Native
NR
No
Negative culture
19
NR
M1
3
Stent retriever
No
2–24 h after
0 at 7 and 90 days
Ambrosioni et al.
72/M
Native
NR
No
Streptococcus dysgalactiae
35
NR
Basilar
3
Stent retriever
No
35–24 h after
6 at 7 days
Ambrosioni et al.
79/F
Prosthetic (biological)
NR
Yes
Negative culture
5
NR
M1
2B
Stent retriever
No
2–24 h after
2 at 7 and 90 days
Ambrosioni et al.
85/M
Prosthetic (biological)
NR
No
Staphylococcus epidermidis
8
NR
M1
3
Stent retriever
No
0–24 h after
0 at 7 days and 6 at 90 days
Bolognese et al.
42/M
Aortic valve
No
No
Streptococcus viridans
3
No
M2
2B
Aspiration
No
0 at 4 weeks
NR
Elodie et al.
70/ F
Aortic valve
Yes
Yes
Negative culture
10
No
M1
NR (recanalised)
Stent retriever
No
1 immediately after
1 at 90 days
Nishino et al.
72/M
Mitral valve
Yes
Yes
Streptococcus salivarius
NR
No
M2
NR (recanalised)
Stent retriever
No
NR
6 at 9 days
Scharf et al.
NR/NR
Mechanical mitral valve and native aortic valve
No
Yes
Streptococcus
12
No
M1
3
Stent retriever and aspiration
No
1
0 at discharge
Sveinsson et al.
33/M
Prosthetic mitral valve
No
Yes
Serratia marcescens
14
No
M1
NR (recanalised)
NR
No
1 at discharge
1 at discharge
Sveinsson et al.
67/M
Prosthetic mitral valve
Yes
Yes
Enterococcus faecalis
13
No
M1
NR (recanalised)
NR
No
3 at discharge
1 after few months
Sveinsson et al.
39/F
Mitral valve
No
No
NR
15
No
M2
NR (recanalised)
NR
No
4 at discharge
2 after 3 months
Ladner et al.
40/NR
Aortic valve
No
No
Enterococcus faecalis
3
No
M1
3
Aspiration
No
0 at 13 days
0 at 13 days
Kim et al.
40/F
Mitral valve
No
No
Streptococcus mitis
15
No
M2
NR (recanalised)
Aspiration
No
3 at 2 days
2 at 3 months
Toeg et al.
73/M
Bioprosthetic aortic valve (replaced 8 weeks prior)
No
No
Gram-positive cocci
20
No
M1, A1 and distal ICA
NR (recanalised)
NR
No
2 immediately after; 0 after 8 months
NR
Akkoyunlu et al.
23/F
Mitral valve
No
No
Gram-positive coccobacillus
NR
No
M1
NR (recanalised)
NR
No
NR
NR
Kang et al.
39/F
Mitral valve
No
No
Streptococcus gordonii
16
No
M1
2b
Stent retriever
No
3 at 4 weeks
NR
Dababneh et al.
67/F
Bovine mitral valve (replaced 6 months prior)
Yes
Yes
Gram-negative vancomycin-resistant rods
NR
No
Between segments M1 and M2
2 or 3
Stent retriever
No
NR
6 at 7 days
Kan et al.
78/F
Aortic valve
No
No
No
16
No
M2
3
Stent retriever
No
12–24 h later
NR
Liang et al.
70/F
Mitral valve
Yes
Yes
Group B Streptococcus agalactiae
24
No
M2
NR (recanalised)
Stent retriever
No
NR, reported no residual neurology
NR
Walker et al.
NR/NR
NR
NR
NR
Coagulase-negative Staphylococcus
14
Yes
NR
NR
Stent retriever
Yes
NR
6
Walker et al.
NR/NR
NR
NR
NR
Enterococcus faecalis
14
Yes
NR
NR
Stent retriever
Yes
NR
6
Bain et al.
24/F
NR
No
Yes
Gram-positive bacilli
18
No
M1
NR (recanalised)
Stent retriever
No
7–24 h after; 2 after 2 months
NR
M male; F female; IE infective endocarditis; IV intravenous; AF atrial fibrillation; OAC oral anticoagulant; NIHSS National Institutes of Health Stroke Scale; ICA internal carotid artery; LVO large vessel occlusion; TICI thrombolysis in cerebral infarction; ICH intracranial haemorrhage; mRS modified Rankin Scale; NR not reported
Table 2
Efficacy outcome
mRS score at 90 days
IE patients treated with MT
mRS score 0–1 at 90 days
36.7% (11/30)*
mRS score 0–2 at 90 days
46.7% (14/30)*
NIHSS at 24 h
  Median score
2.5 (IQR 5.75)
Change in NIHSS score from baseline to 24 h
  Median change
− 14 (IQR 10)
MT mechanical thrombectomy; IE infective endocarditis; NIHSS National Institutes of Health Stroke Scale; mRS modified Rankin Scale; IQR interquartile range
*mRS score at 90 days is not available for seven patients

Case series

Case 1

A 30-year-old female patient was brought to our emergency department 4 h after she developed right-sided hemiparesis, aphasia, right homonymous hemianopia, right central facial paralysis and reduced sensation in the right side of the body while she was at the gym (NIHSS 22). A month earlier, she presented to her local general practitioner (GP) with symptoms including sore throat, lethargy and general malaise. Her GP found no specific abnormalities on thorough general examination. CT of the brain showed already established changes in the left middle cerebral artery territory with an Alberta stroke program early CT score (ASPECTS) of 6. CT angiography of the brain showed a thrombus in the terminal segment of the left internal carotid artery (ICA). Thrombolysis was not performed because of the low ASPECT score on the CT brain. Mechanical thrombectomy was performed using a combination of aspiration and stent retriever, and partial recanalization was obtained (TICI 2a). A day later, the CT of the brain showed haemorrhagic transformation with an intraparenchymal haematoma centred in the left lentiform nucleus and her NIHSS was unchanged. At the same time, she developed rising fever and elevated CRP (145 mg/L). On day 4 of her admission, transthoracic echocardiogram showed vegetation on the aortic valve with associated severe aortic regurgitation. Left ventricular function was unimpaired. Blood cultures were positive for Gram-negative diplococcus, identified as Neisseria gonorrhoeae. She was therefore treated with ceftriaxone and azithromycin. After 3 months, her mRS was 3.

Case 2

A 67-year-old male patient was transferred from a local hospital to our emergency department 3 h after sudden onset of left sided weakness, sensory disturbance and dysarthria. His NIHSS was 17. The patient was initially admitted for infective endocarditis of his native mitral valve and he was supposed to valve replacement surgery soon. Blood culture was positive for Gemella morbillorum. Computer tomography (CT) with CT angiography showed an occlusion of the M1 segment of the right middle cerebral artery. ASPECT score was 8 (Fig. 2a and b). Because of the evidence of endocarditis, intravenous thrombolysis was not considered an option. However, based on the large vessel occlusion, mechanical thrombectomy was performed under local anaesthetic with sedation. Endovascular thrombectomy was then performed with successful aspiration of the clot (TICI 3) (Fig. 2c and d). No immediate complications were recorded after the procedure. After 24 h, his NIHSS dropped to 13. Mitral valve replacement surgery was successfully performed 1 month later. At neurological follow-up after 3 months, the patient showed no neurological deficits (NIHSS 0) and mRS score of 0.

Case 3

A 65-year-old female patient with staphylococcal native mitral valve infective endocarditis had a witnessed onset of right-sided hemiparesis and aphasia (NIHSS 18). The patient was initially admitted in a local hospital for infective endocarditis and treated with teicoplanin and gentamicin. The patient was brought to our emergency department 3 h and 45 min after she developed her stroke symptoms. Her past medical history included also liver cirrhosis, type 2 diabetes, hypertension and breast cancer. CT angiography showed an occlusion of both M2 divisional branches. Intravenous thrombolysis was contraindicated because of the evidence of endocarditis. Mechanical thrombectomy was considered due to the large vessel occlusion. Despite several attempts at aspiration, the clot remained in situ with the final angiography demonstrating a subtotal occlusion of both the M2 divisional branches (TICI 1). After 24 h, her NIHSS was 21 and the CT showed no haemorrhagic transformation. At neurological follow-up after 3 months, her mRS score was 4.

Results

The database search yielded 431 relevant records published until January 2020. Nineteen articles fulfilled the eligibility criteria [826]. Three articles (16%) were case series while sixteen (84%) were single case report.

Synthesis of results

Table 1 shows the characteristics of patients with stroke and infective endocarditis treated with mechanical thrombectomy. The median age of the patients was 67 years old (IQR 32.75). For three patients, their age was not reported. Eleven patients were men (36.7%) while for four patients (13.3%), the gender was not documented. The median baseline NIHSS resulted to be 15 (IQR 7). The most common site of the large vessel occlusion was the M1 (56.7%). After the thrombectomy, nine patients (30%) had TICI score of 3 while the TICI score of 2b was obtained in four patients (13.3%). After the treatment, four patients (13.3%) experienced intracranial haemorrhage. After the procedure, the median NIHSS dropped to 2.5 (IQR 5.75) (Table 2).
After a follow-up of 90 days, seven patients were dead (mRS = 6) (23.3%) while fourteen (46.7%) were functionally independent (mRS ≤ 2) (Table 2) (Fig. 3). Of note, mRS score at 90 days was not available for seven patients.

Discussion

Our review described the clinical presentation, management and outcome of patients treated with mechanical thrombectomy for thrombotic stroke due to infective endocarditis. Although mechanical thrombectomy is not recognised as the standard of care for acute stroke secondary to infective endocarditis, this review provides evidence of consistent benefit for endovascular treatment on disability in these patients. Indeed, in our review, 36.7% of the patients with stroke due to infective endocarditis treated with mechanical thrombectomy had a 90-day mRS ≤ 1 while 46.7% of the patients had a mRS ≤ 2 at 90 days. Overall, almost half of the patients with stroke due to infective endocarditis treated with mechanical thrombectomy were functionally independent after 3 months. Many previous studies showed that the occurrence of neurologic complications during infective endocarditis were associated with an increased risk of mortality [1, 2, 4, 27, 28]. More specifically, Thuny et al. [29] demonstrated that the risk of death differed according to the type of cerebrovascular disease. Patients with silent brain infarcts or transient ischemic attack had a better prognosis, whereas large stroke resulted to be a strong predictor of mortality independently of the other prognostic factors. Moreover, the cause of death in these patients was a direct consequence of this neurologic event. One explanation of this finding is the fact that the absence of large brain injuries carried a better prognosis and allowed early surgery to be performed with a low operative risk. This result underlines the critical need of safe reperfusion therapy for acute ischemic stroke due to infective endocarditis for salvaging ischemic brain that is not already infarcted to avoid dramatic cerebral damages.
To date, treatment with intravenous alteplase is not recommended for patients with acute ischemic stroke and symptoms consistent with infective endocarditis because of the increased risk of intracranial haemorrhage [30]. Despite the fact that the fibrinolysis might promote reperfusion through cerebral vessels occluded by septic emboli, histopathological studies suggested that cerebral infarcts caused by septic emboli are particularly prone to haemorrhagic transformation as a result of septic arteritis with erosion of the arterial wall in the recipient vessel, with or without the formation of mycotic aneurysms. The use of mechanical thrombectomy for ischemic stroke with large vessel occlusion due to septic emboli has been documented in few patients in literature so far [28]. In our review, we found that only 13.3% of the patients with endocarditis-related acute stroke treated with thrombectomy suffered an intracranial haemorrhage after the treatment. Bettencourt et al. [28] showed that the use of intravenous alteplase alone or combined with mechanical thrombectomy was associated with a 4-fold increased risk of intracranial haemorrhage compared with mechanical thrombectomy alone. The severe bleeding complications associated with the use of intravenous alteplase may suggest that mechanical thrombectomy alone should be considered in selected patients with infective endocarditis if there is a documented large vessel occlusion.
The patterns of endocarditis-associated stroke observed in previous studies are very heterogenous. Previous studies, using conventional and DWI MRI [31] [32, 33], showed that patients with acute ischemic stroke and infective endocarditis can have a variety of ischemic lesions, including single cortical, territorial, disseminated punctate and disseminated small and large lesions in multiple vascular territories. Infarction of the middle cerebral artery territory resulted to be the most common anatomical lesion, with involvement of the middle cerebral artery tree [31]. In this review, 93.3% of the patients (28/30) treated with mechanical thrombectomy had a large vessel occlusion in the anterior circulation. Previous studies proved the value of thrombectomy in anterior circulation acute ischemic stroke within the first 6 h of symptom onset [3436]. In MR CLEAN [34], 33% of patients achieved a good clinical outcome being functionally independent with thrombectomy versus 19% with medical therapy; in EXTEND-IA [35], the respective outcomes were 71% versus 40%; in SWIFT PRIME [36], they were 60% versus 35%. Recently, two recent multicentre randomized controlled trials of mechanical thrombectomy of the anterior circulation initiated at a later time windows of up to 16 h and 24 h from symptom onset have shown that endovascular therapy is safe and highly effective in carefully selected patients with advanced imaging in comparison with medical management alone [37, 38]. The results of our review suggest that the use of thrombectomy might be an efficient and safe treatment for patients with acute large vessel occlusion of the anterior circulation associated with endocarditis and might help improve outcome; however, age, time from symptom onset, clinical severity of stroke symptoms, pre-stroke level of functioning and anatomic location of the large vessel occlusion are the most important determinants of candidacy for mechanical thrombectomy in this cohort of patients.
This study has different limitations. In first instance, our search did not find any randomized controlled trials to investigate the efficacy and safety of the mechanical thrombectomy in patients with acute stroke due to infective endocarditis as our review was based only on single case reports or case series. Secondly, there were some data missing and this made difficult to compare the results. Finally, we draw our conclusions in favour of the use of thrombectomy based on a potential publication bias.
In conclusion, based on our review, the use of mechanical thrombectomy in patients with large vessel occlusion due to endocarditis-associated stroke should be considered on a case by case base as the safety has not well established yet. Further research on risk stratification is needed to drive clinician during the decision-making process.

Compliance with ethical standards

Conflict of interest

The author declares that he has no conflict of interest.

Ethical approval

Not applicable
Informed consent was obtained by the patients.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Literatur
3.
Zurück zum Zitat Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö Å, Ackerholm P, Andersson R, Olaison L (2008) Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47:23–30. https://doi.org/10.1086/588663CrossRefPubMed Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö Å, Ackerholm P, Andersson R, Olaison L (2008) Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 47:23–30. https://​doi.​org/​10.​1086/​588663CrossRefPubMed
4.
Zurück zum Zitat Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, Lavoué S, Kouatchet A, Pajot O, Mekontso Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Tabah A, Trouillet JL, Wolff M, ENDOcardite en REAnimation Study Group (2011) Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 39:1474–1481. https://doi.org/10.1097/CCM.0b013e3182120b41CrossRefPubMed Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, Lavoué S, Kouatchet A, Pajot O, Mekontso Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Tabah A, Trouillet JL, Wolff M, ENDOcardite en REAnimation Study Group (2011) Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 39:1474–1481. https://​doi.​org/​10.​1097/​CCM.​0b013e3182120b41​CrossRefPubMed
11.
Zurück zum Zitat Toeg HD, Al-Atassi T, Kalidindi N, Iancu D, Zamani D, Giaccone R, Masters RG (2014) Endovascular treatment for cerebral septic embolic stroke. J Stroke Cerebrovasc Dis 23:e375–e377CrossRefPubMed Toeg HD, Al-Atassi T, Kalidindi N, Iancu D, Zamani D, Giaccone R, Masters RG (2014) Endovascular treatment for cerebral septic embolic stroke. J Stroke Cerebrovasc Dis 23:e375–e377CrossRefPubMed
16.
Zurück zum Zitat Liang (2012) Infective endocarditis complicated by acute ischemic stroke from septic embolus: successful solitaire FR thrombectomy. Cardiol Res 3:277–280PubMedPubMedCentral Liang (2012) Infective endocarditis complicated by acute ischemic stroke from septic embolus: successful solitaire FR thrombectomy. Cardiol Res 3:277–280PubMedPubMedCentral
19.
Zurück zum Zitat Sgreccia A, Carità G, Coskun O, Di Maria F, Benamer H, Tisserand M, Scemama A, Rodesch G, Lapergue B, Consoli A (2019) Acute ischemic stroke treated with mechanical thrombectomy and fungal endocarditis: a case report and systematic review of the literature. J Neuroradiol. https://doi.org/10.1016/j.neurad.2019.03.003 Sgreccia A, Carità G, Coskun O, Di Maria F, Benamer H, Tisserand M, Scemama A, Rodesch G, Lapergue B, Consoli A (2019) Acute ischemic stroke treated with mechanical thrombectomy and fungal endocarditis: a case report and systematic review of the literature. J Neuroradiol. https://​doi.​org/​10.​1016/​j.​neurad.​2019.​03.​003
20.
Zurück zum Zitat Ambrosioni J, Urra X, Hernández-Meneses M, Almela M, Falces C, Tellez A, Quintana E, Fuster D, Sandoval E, Vidal B, Tolosana JM, Moreno A, Chamorro A, Miró JM, Hospital Clínic Infective Endocarditis Study Group, J M M, J A, Pericàs JM, A T, M H M, A M, de la Mària CG, Garcia-Gonzalez J, Marco F, M A, Vila J, E Q, E S, Paré JC, C F, Pereda D, Cartañá R, Ninot S, Azqueta M, Sitges M, B V, Pomar JL, Castella M, J M T, Ortiz J, Fita G, Rovira I, D F, Ramírez J, Brunet M, Soy D, Castro P, Llopis J (2018) Mechanical thrombectomy for acute ischemic stroke secondary to infective endocarditis. Clin Infect Dis 66:1286–1289CrossRefPubMed Ambrosioni J, Urra X, Hernández-Meneses M, Almela M, Falces C, Tellez A, Quintana E, Fuster D, Sandoval E, Vidal B, Tolosana JM, Moreno A, Chamorro A, Miró JM, Hospital Clínic Infective Endocarditis Study Group, J M M, J A, Pericàs JM, A T, M H M, A M, de la Mària CG, Garcia-Gonzalez J, Marco F, M A, Vila J, E Q, E S, Paré JC, C F, Pereda D, Cartañá R, Ninot S, Azqueta M, Sitges M, B V, Pomar JL, Castella M, J M T, Ortiz J, Fita G, Rovira I, D F, Ramírez J, Brunet M, Soy D, Castro P, Llopis J (2018) Mechanical thrombectomy for acute ischemic stroke secondary to infective endocarditis. Clin Infect Dis 66:1286–1289CrossRefPubMed
25.
Zurück zum Zitat Sveinsson O, Herrman L, Holmin S (2016) Intra-arterial mechanical thrombectomy: an effective treatment for ischemic stroke caused by endocarditis. Case Rep Neurol 8:229–233CrossRefPubMedPubMedCentral Sveinsson O, Herrman L, Holmin S (2016) Intra-arterial mechanical thrombectomy: an effective treatment for ischemic stroke caused by endocarditis. Case Rep Neurol 8:229–233CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Ladner TR, Davis BJ, He L, Kirshner HS, Froehler MT, Mocco J (2014) Complex decision-making in stroke: preoperative mechanical thrombectomy of septic embolus for emergency cardiac valve surgery. BMJ Case Rep 2014:1–4 Ladner TR, Davis BJ, He L, Kirshner HS, Froehler MT, Mocco J (2014) Complex decision-making in stroke: preoperative mechanical thrombectomy of septic embolus for emergency cardiac valve surgery. BMJ Case Rep 2014:1–4
29.
Zurück zum Zitat Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A, Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G (2007) Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 28:1155–1161. https://doi.org/10.1093/eurheartj/ehm005CrossRefPubMed Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A, Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G (2007) Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 28:1155–1161. https://​doi.​org/​10.​1093/​eurheartj/​ehm005CrossRefPubMed
30.
Zurück zum Zitat Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE, American Heart Association Stroke Council and Council on Epidemiology and Prevention (2016) Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke. 47:581–641. https://doi.org/10.1161/str.0000000000000086CrossRefPubMed Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE, American Heart Association Stroke Council and Council on Epidemiology and Prevention (2016) Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke. 47:581–641. https://​doi.​org/​10.​1161/​str.​0000000000000086​CrossRefPubMed
33.
Zurück zum Zitat Bakshi R, Wright PD, Kinkel PR, Bates VE, Mechtler LL, Kamran S, Pullicino PM, Sirotkin I, Kinkel WR (1999) Cranial magnetic resonance imaging findings in bacterial endocarditis: the neuroimaging spectrum of septic brain embolization demonstrated in twelve patients. J Neuroimaging 9:78–84. https://doi.org/10.1111/jon19999278CrossRefPubMed Bakshi R, Wright PD, Kinkel PR, Bates VE, Mechtler LL, Kamran S, Pullicino PM, Sirotkin I, Kinkel WR (1999) Cranial magnetic resonance imaging findings in bacterial endocarditis: the neuroimaging spectrum of septic brain embolization demonstrated in twelve patients. J Neuroimaging 9:78–84. https://​doi.​org/​10.​1111/​jon19999278CrossRefPubMed
34.
Zurück zum Zitat Berkhemer OA, Fransen PSS, Beumer D, van den Berg L, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen M, Staals J, Hofmeijer J, van Oostayen J, Lycklama à Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk L, Kappelle LJ, Lo RH, van Dijk E, de Vries J, de Kort PL, van Rooij W, van den Berg J, van Hasselt B, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog H, Gerrits DG, van den Berg-Vos R, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam W, Roos YB, van der Lugt A, van Oostenbrugge R, Majoie CB, Dippel DW, MR CLEAN Investigators (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20. https://doi.org/10.1056/NEJMoa1411587CrossRefPubMed Berkhemer OA, Fransen PSS, Beumer D, van den Berg L, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen M, Staals J, Hofmeijer J, van Oostayen J, Lycklama à Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk L, Kappelle LJ, Lo RH, van Dijk E, de Vries J, de Kort PL, van Rooij W, van den Berg J, van Hasselt B, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog H, Gerrits DG, van den Berg-Vos R, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam W, Roos YB, van der Lugt A, van Oostenbrugge R, Majoie CB, Dippel DW, MR CLEAN Investigators (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20. https://​doi.​org/​10.​1056/​NEJMoa1411587CrossRefPubMed
35.
Zurück zum Zitat Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM, EXTEND-IA Investigators (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018. https://doi.org/10.1056/NEJMoa1414792CrossRefPubMed Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM, EXTEND-IA Investigators (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018. https://​doi.​org/​10.​1056/​NEJMoa1414792CrossRefPubMed
37.
Zurück zum Zitat Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718. https://doi.org/10.1056/NEJMoa1713973CrossRefPubMedPubMedCentral Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718. https://​doi.​org/​10.​1056/​NEJMoa1713973CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG, DAWN Trial Investigators (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21. https://doi.org/10.1056/NEJMoa1706442CrossRefPubMed Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG, DAWN Trial Investigators (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21. https://​doi.​org/​10.​1056/​NEJMoa1706442CrossRefPubMed
Metadaten
Titel
Endovascular treatment of ischemic large-vessel stroke due to infective endocarditis: case series and review of the literature
verfasst von
Lucio D’Anna
Publikationsdatum
22.07.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 12/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04599-9

Weitere Artikel der Ausgabe 12/2020

Neurological Sciences 12/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.